India  

AstraZeneca COVID-19 vaccine 90% effective: Report

Mid-Day Monday, 23 November 2020
AstraZeneca announced Monday that positive high-level results from an interim analysis of clinical trials of the COVID-19 vaccine candidate in the UK and Brazil showed it was highly effective in preventing the disease, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants...
0
shares
ShareTweetSavePostSend
 
Video Credit: FOX 4 Now Florida - Published
News video: COVID vaccine distribution plans

COVID vaccine distribution plans 01:40

COVID vaccine distribution plans proceed as more companies file paperwork for emergency use.

You Might Like


Related videos from verified sources

FDA To Discuss Emergency Authorization For Pfizer COVID-19 Vaccine [Video]

FDA To Discuss Emergency Authorization For Pfizer COVID-19 Vaccine

An FDA advisory committee will meet next month to discuss an emergency use authorization. The emergency use authorization would be for Pfizer's COVID-19 vaccine. Earlier this week, Pfizer said..

Credit: Wochit     Duration: 00:39Published
'Role of pollution in higher Covid deaths...': Delhi CM Kejriwal #HTLS2020 [Video]

'Role of pollution in higher Covid deaths...': Delhi CM Kejriwal #HTLS2020

Delhi's annual wave of air pollution has coincided with the Covid-19 pandemic this year. Speaking at the Hindustan Times Leadership Summit 2020, Chief Minister Arvind Kejriwal said that pollution..

Credit: HT Digital Content     Duration: 05:11Published
A look inside Tennessee's COVID-19 Vaccination plan [Video]

A look inside Tennessee's COVID-19 Vaccination plan

With Tennessee officials saying widespread distribution of a COVID-19 vaccine is still several months away, we are taking a closer look at the plan in place to distribute the vaccine in Tennessee.

Credit: NewsChannel 5 Nashville     Duration: 01:48Published

Related news from verified sources

Covid-19: India to get 100 million Astra vaccine shots by next month

The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 shot, aiming to have 100 million doses ready by December for an...
IndiaTimes

AstraZeneca manufacturing error clouds Oxford vaccine study results

AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental...
Mid-Day

Trials show third COVID-19 vaccine is cheaper, effective

AstraZeneca said on Monday that late-stage trials showed its coronavirus vaccine was up to 90 per cent effective, giving public health officials hope they may...
Mid-Day